NCT00183859View on ClinicalTrials.gov

Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
AdenocarcinomaGastric Cancer
Interventions
DRUG

irinotecan

Intraperitoneal Irinotecan given every three weeks

Trial Locations (1)

90033

U.S.C. / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT00183859 - Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | Biotech Hunter | Biotech Hunter